{"id":2277,"date":"2014-04-11T15:23:11","date_gmt":"2014-04-11T19:23:11","guid":{"rendered":"https:\/\/www.bu.edu\/amyloid\/?page_id=2277"},"modified":"2015-06-19T10:00:36","modified_gmt":"2015-06-19T14:00:36","slug":"_2014","status":"publish","type":"page","link":"https:\/\/www.bu.edu\/amyloid\/research\/publications\/_2014\/","title":{"rendered":"2014"},"content":{"rendered":"

Reddi HV, Jenkins S, Theis J, Thomas BC, Connors LH, Van Rhee F, Highsmith WE.<\/strong>\u00a0 Homozygosity for the V122I mutation in transthyretin is associated with earlier onset of cardiac amyloidosis in the African American population in the seventh decade of life.\u00a0 J Mol Diagn,<\/em>\u00a016(1):68-74, 2014.\u00a0 <\/span>View in:\u00a0PubMed<\/a><\/p>\n

Mahmood S, Palladini G, Sanchorawala V, Wechalekar A.<\/strong>\u00a0 Update on treatment of light chain amyloidosis.\u00a0 Haematologica, <\/em>(2):209-21, 2014.\u00a0 <\/span>View in: PubMed<\/a><\/p>\n

Merlini G, Comenzo RL, Seldin DC, Wechalekar A, Gertz MA.<\/strong>\u00a0 Immunoglobulin light chain amyloidosis.\u00a0 Expert Rev Hematol, <\/em>7(1):143-56, 2014.\u00a0 View in: PubMed<\/a><\/p>\n

Gray Gilstrap L, Niehaus E, Malhotra R, Ton VK, Watts J, Seldin DC, Madsen JC, Semigran MJ.<\/strong>\u00a0 Predictors of survival to orthotopic heart transplant in patients with light chain amyloidosis.\u00a0 J Heart Lung Transplant,<\/em>\u00a033(2):149-56, 2014.\u00a0 <\/span>View in: PubMed<\/a><\/p>\n

Girnius S, Seldin DC, Meier-Ewert HK, Sloan JM, Quillen K, Ruberg FL, Berk JL, Doros G, Sanchorawala V.<\/strong>\u00a0 Safety and efficacy of high-dose melphalan and auto-SCT in patients with AL amyloidosis and cardiac involvement.\u00a0 Bone Marrow Transplant,<\/em>\u00a049(3):434-9, 2014.\u00a0 <\/span>View in: PubMed<\/a><\/p>\n

Phay M, Blinder V, Macy S, Greene MJ, Wooliver DC, Liu W, Planas A, Walsh DM, Connors LH, Primmer SR, Planque SA, Paul S, O’Nuallain B.<\/strong>\u00a0 Transthyretin aggregate-specific antibodies recognize cryptic epitopes on patient-derived amyloid fibrils.\u00a0 Rejuvenation Res,<\/em>\u00a017(2):97-104, 2014.\u00a0 <\/span>View in: PubMed<\/a><\/p>\n

von Keudell G, Sanchorawala V, O”Hara C, C Seldin D, Sloan JM.<\/strong>\u00a0 Simultaneous presentation of kappa-restricted chronic lymphocytic leukemia and lambda light chain AL amyloidosis.\u00a0 Amyloid: J Prot Folding Disorders<\/em>, 21(2):124-7, 2014.\u00a0 <\/span>View in:\u00a0PubMed<\/a><\/span><\/span><\/p>\n

Lichtman EI, Seldin DC, Shelton A, Sanchorawala V.<\/strong>\u00a0 Single agent lenalidomide three times a week induces hematologic responses in AL amyloidosis patients on dialysis.\u00a0 Am J Hematol,<\/em>\u00a089(7):706-8, 2014.\u00a0 <\/span>View in: PubMed<\/a><\/span><\/p>\n

Lee SY, Sanchorawala V, Seldin DC, Mark Sloan J, Andrea N, Quillen K.<\/strong>\u00a0 Plerixafor-augmented peripheral blood stem cell mobilization in AL amyloidosis with cardiac involvement: a case series.\u00a0 Amyloid: J Prot Folding Disorders<\/em>, 21(3):149-53, 2014.\u00a0 <\/span>View in: PubMed<\/a><\/p>\n

Ruzhansky K, Scoon J, Weimer LH, Maurer MS, Berk JL, Brannagan TH.<\/strong>\u00a0 Discordant phenotype in monozygotic female twins with Lys35Thr TTR familial amyloidotic polyneuropathy.\u00a0 J Clin Neuromuscul Dis,<\/em>\u00a016(1):1-6, 2014.\u00a0 <\/span>View in: PubMed<\/a><\/p>\n

Suanprasert N, Berk JL, Benson MD, Dyck PJ, Klein CJ, Gollob JA, Bettencourt BR, Karsten V, Dyck PJ.<\/strong>\u00a0 Retrospective study of a TTR FAP cohort to modify NIS+7 for therapeutic trials.\u00a0 J Neurol Sci,<\/em> 344(1-2):121-8, 2014.\u00a0 <\/span>View in: PubMed<\/a><\/p>\n

Guan J, Mishra S, Qiu Y, Shi J, Trudeau K, Las G, Liesa M, Shirihai OS, Connors LH, Seldin DC, Falk RH, MacRae CA, Liao R.<\/strong>\u00a0 Lysosomal dysfunction and impaired autophagy underlie the pathogenesis of amyloidogenic light chain-mediated cardiotoxicity.\u00a0 EMBO Mol Med<\/em>, 6(11):1493-507, 2014.\u00a0 <\/span>View in: PubMed<\/a><\/p>\n

Reece DE, Hegenbart U, Sanchorawala V, Merlini G, Palladini G, Blad\u00e9 J, Fermand JP, Hassoun H, Heffner L, Kukreti V, Vescio RA, Pei L, Enny C, Esseltine DL, van de Velde H, Cakana A, Comenzo RL.<\/strong>\u00a0 Long-term follow-up from a phase 1\/2 study of single-agent bortezomib in relapsed systemic AL amyloidosis.\u00a0 Blood<\/em>, 24(16):2498-506, 2014.\u00a0 <\/span>View in: PubMed<\/a><\/p>\n

Freeman B, Brauneis D, Seldin DC, Quillen K, Sloan JM, Renteria AS, Shelton AC, Teschner T, Finn KT, Sanchorawala V.<\/strong>\u00a0 Hospital admissions following outpatient administration of high-dose melphalan and autologous SCT for AL amyloidosis.\u00a0 Bone Marrow Transplant<\/em>, 49(10):1345-6, 2014.\u00a0 <\/span>View in: PubMed<\/a><\/p>\n

Sanchorawala V.<\/strong>\u00a0 High dose melphalan and autologous peripheral blood stem cell transplantation in AL amyloidosis.\u00a0 Hematol Oncol Clin North Am<\/em>, 28(6):1131-44, 2014.\u00a0 <\/span>View in: PubMed<\/a><\/p>\n

Fu J, Seldin DC, Berk JL, Sun F, O”Hara C, Cui H, Sanchorawala V.<\/strong>\u00a0 Lymphadenopathy as a manifestation of amyloidosis: a case series.\u00a0 \u00a0Amyloid: J Prot Folding Disorders<\/em>,\u00a021(4):256-60, 2014.\u00a0 <\/span>View in: PubMed<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Reddi HV, Jenkins S, Theis J, Thomas BC, Connors LH, Van Rhee F, Highsmith WE.\u00a0 Homozygosity for the V122I mutation in transthyretin is associated with earlier onset of cardiac amyloidosis in the African American population in the seventh decade of life.\u00a0 J Mol Diagn,\u00a016(1):68-74, 2014.\u00a0 View in:\u00a0PubMed Mahmood S, Palladini G, Sanchorawala V, Wechalekar A.\u00a0 […]<\/p>\n","protected":false},"author":8474,"featured_media":0,"parent":88,"menu_order":5,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/www.bu.edu\/amyloid\/wp-json\/wp\/v2\/pages\/2277"}],"collection":[{"href":"https:\/\/www.bu.edu\/amyloid\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.bu.edu\/amyloid\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.bu.edu\/amyloid\/wp-json\/wp\/v2\/users\/8474"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bu.edu\/amyloid\/wp-json\/wp\/v2\/comments?post=2277"}],"version-history":[{"count":19,"href":"https:\/\/www.bu.edu\/amyloid\/wp-json\/wp\/v2\/pages\/2277\/revisions"}],"predecessor-version":[{"id":2481,"href":"https:\/\/www.bu.edu\/amyloid\/wp-json\/wp\/v2\/pages\/2277\/revisions\/2481"}],"up":[{"embeddable":true,"href":"https:\/\/www.bu.edu\/amyloid\/wp-json\/wp\/v2\/pages\/88"}],"wp:attachment":[{"href":"https:\/\/www.bu.edu\/amyloid\/wp-json\/wp\/v2\/media?parent=2277"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}